• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
3,3′-Diindolylmethane

3,3′-Diindolylmethane

Product ID D3232
Cas No. 1968-05-4
Purity ≥98%
Product Unit SizeCostQuantityStock
1 g $50.40 In stock
5 g $136.50 In stock
10 g $236.30 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

3,3’-Diindolylmethane (DIM) is found in cruciferous vegetables; it exhibits anti-inflammatory, immunosuppressive, antioxidative, anti-diabetic, anti-fibrotic, anti-metastatic, anticancer chemotherapeutic, and chemopreventive activities. DIM acts as an agonist at the aryl hydrocarbon receptor. DIM increases levels of Foxp3 and function of Treg cells and decreases expression of toll-like receptor 4 (TLR4) and Th17 cells, preventing hepatic steatosis and inflammation in vivo. DIM also prevents the development of experimental autoimmune encephalitis (EAE) by suppressing T cell activity. In vivo, this compound decreases glucose levels, insulin levels, and Hb1Ac by increasing activity of glucokinase and glucose-6-phosphate dehydrogenase and decreasing activity of glucose-6-phosphatase and fructose-1,6-bisphosphatase. DIM also prevents the development of liver fibrosis in vivo. In cellular and animal models of nasopharyngeal carcinoma, DIM inhibits cellular invasion and metastasis and tumor growth; it also decreases activity of HDAC2.

Product Info

Cas No.

1968-05-4

Purity

≥98%

Formula

C17H14N2

Formula Wt.

246.31

IUPAC Name

3-(1H-indol-3-ylmethyl)-1H-indole

Synonym

3,3'-Diindolymethane, 3,3'-Methylenebis-1H-indole, DIM

Melting Point

163-165°C

Solubility

Soluble in DMSO (200 mg/mL). Insoluble in water.

Appearance

Off white powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

D3232 MSDS PDF

Info Sheet

D3232 Info Sheet PDF

References

Liu Y, She W, Wang F, et al. 3, 3'-diindolylmethane alleviates steatosis and the progression of NASH partly through shifting the imbalance of Treg/Th17 cells to Treg dominance. Int Immunopharmacol. 2014 Oct 1. [Epub ahead of print]. PMID: 25281898.

Rouse M, Rao R, Nagarkatti M, et al. 3,3'-diindolylmethane ameliorates experimental autoimmune encephalomyelitis by promoting cell cycle arrest and apoptosis in activated T cells through microRNA signaling pathways. J Pharmacol Exp Ther. 2014 Aug;350(2):341-52. PMID: 24898268.

Wu T, Chen C, Li F, et al. 3,3'-Diindolylmethane inhibits the invasion and metastasis of nasopharyngeal carcinoma cells in vitro and in vivo by regulation of epithelial mesenchymal transition. Exp Ther Med. 2014 Jun;7(6):1635-1638. PMID: 24926357.

Poornima J, Mirunalini S. Regulation of carbohydrate metabolism by indole-3-carbinol and its metabolite 3,3'-diindolylmethane in high-fat diet-induced C57BL/6J mice. Mol Cell Biochem. 2014 Jan;385(1-2):7-15. PMID: 24072613.

Zhang Z, Gao Z, Hu W, et al. 3,3'-Diindolylmethane ameliorates experimental hepatic fibrosis via inhibiting miR-21 expression. Br J Pharmacol. 2013 Oct;170(3):649-60. PMID: 23902531.

Chen C, Chen SM, Xu B, et al. In vivo and in vitro study on the role of 3,3'-diindolylmethane in treatment and prevention of nasopharyngeal carcinoma. Carcinogenesis. 2013 Aug;34(8):1815-21. PMID: 23568953.

Beaver LM, Yu TW, Sokolowski EI, et al. 3,3'-Diindolylmethane, but not indole-3-carbinol, inhibits histone deacetylase activity in prostate cancer cells. Toxicol Appl Pharmacol. 2012 Sep 15;263(3):345-51. PMID: 22800507.

Cho HJ, Seon MR, LLee YM, et al. 3,3’-Diindolylmethane suppresses the inflammatory response to lipopolysacharide in murine macrophages. J Nutr. 2008 Jan;138(1):17-23. PMID: 18156398.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • E6814

    Erdosteine

    Thiol derivative, antioxidant.

    ≥98%
  • P200000

    PF-3845

    FAAH inhibitor.

    ≥98%
  • A7210

    L-(+)-Ascorbic Acid

    Form of vitamin C found in various plant and fo...

    ≥98%
  • H5748

    D,L-Homocysteine Thiolactone Hydrochloride

    Heterocyclic derivative of cysteine, alters pro...

    ≥99%
  • T3034

    Thienylethyl Isothiocyanate

    Thienylbutyl ITC analog.

    ≥98%
  • A2050

    Aflatoxin G2

    Mycotoxin produced by species of Aspergillus; D...

    ≥98%
  • M324083

    Micafungin

    Echinocandin

    ≥95%
  • A5160

    Ampicillin Trihydrate

    β-lactam; transpeptidase inhibitor.

    ≥97%
  • A9713

    AZD-3514

    Androgen receptor downregulator.

    ≥98%
  • C0016

    Caerulomycin A

    Bipyridamine toxin.

    ≥96%
  • D5649

    Domperidone

    D2/3 antagonist, hERG K+ channel blocker.

    ≥98%
  • P3313

    Pidotimod

    Immunostimulator, adjuvant.

    ≥98%
  • A7085

    Arvanil

    CB1 agonist, TRPV1 agonist.

    ≥98%
  • C3576

    Citreoviridin A

    Mycotoxin; F1F0 ATP synthase inhibitor.

    ≥95%
  • N4972

    NMS-873

    Valosin-containing protein inhibitor.

    ≥98%
  • O7377

    Osthole

    O-methylated coumarin; Ca2+ channel blocker.

    ≥98%
  • A4806

    Ambroxol Hydrochloride

    Expectorant.

    ≥98%
  • C0170

    N-(4-Carbethoxyphenyl)retinamide

    Retinoid, differentiation inducer.

    ≥98%
  • R1877

    all-trans-Retinol, ≥98 %

    Diterpene vitamin A; RAR/RXR agonist.

    ≥98%
  • C3210

    Ciglitazone

    Thiazolidinedione; PPARγ agonist.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2025 LKT Laboratories, All Rights Reserved - Products for research use only